Medical device manufacturers face a unique financial challenge: buyers often need Net 60-90 terms to afford high-value equipment purchases averaging $230,000, but waiting months for payment strains cash flow and exposes manufacturers to default risk. B2B Buy Now, Pay Later (BNPL) platforms solve this dilemma by advancing payment to sellers within 24-48 hours while extending flexible terms to qualified buyers. For medical device companies, the right BNPL partner must handle complex healthcare compliance requirements, integrate seamlessly with existing ERP systems, and understand the nuances of medical equipment sales cycles. Resolve's B2B Net Terms platform stands out as the industry's most specialized solution, purpose-built for these exact challenges. We've analyzed 15+ platforms and ranked the top 10 based on medical device specialization, transaction capacity, healthcare compliance, and integration capabilities.
Resolve is the only BNPL platform engineered specifically for medical device manufacturers, addressing the industry's unique needs with non-recourse invoice advancement, AI-powered credit decisions, and support for transactions averaging $230,000.
Resolve transforms payment processing from a cost center into a sales growth engine by eliminating the traditional trade-offs between offering flexible terms and maintaining healthy cash flow. The platform's non-recourse model means manufacturers transfer the majority of credit risk to Resolve, with no liability for buyer defaults. This protection becomes especially valuable for medical device manufacturers dealing with high-value transactions where a single default could significantly impact financial performance.
The platform's AI-powered credit assessment evaluates thousands of buyer data points to generate dynamic, scalable credit decisions within 24 hours. Resolve's experts—formerly of Amazon, PayPal, and Fortune 500 firms—deliver deeper credit insights than traditional bureaus, enabling instant approvals that help buyers check out with no paperwork or waiting.
Medical device manufacturers using Resolve report significant improvements in sales conversion and operational efficiency. The platform's flexible payment terms directly enhance the buyer experience, creating competitive advantages in an industry where purchasing decisions often involve multiple stakeholders and extended approval processes. By removing payment friction, Resolve enables manufacturers to focus on demonstrating clinical value rather than negotiating payment terms.
Resolve offers comprehensive integrations with leading platforms across the medical device manufacturer's tech stack:
The platform fits directly into your B2B ecommerce and accounting stack with instant plug-ins, flexible APIs, and automated syncing. No need to manually enter customer information—Resolve syncs with your existing systems and auto-imports required data, ensuring seamless payment reconciliation and financial reporting.
Resolve manages the entire credit approval, underwriting, and collections process, allowing medical device manufacturers to offer terms while protecting cash flow. The platform uses AI agents to automate payment reminders and reduce friction in collections, while also providing manual collection support when needed. For large medical device orders, manufacturers receive up to 90% of the invoice value upfront, eliminating exposure to late payments or defaults while Resolve actively manages collections.
Getting Started: Visit resolvepay.com for a personalized demo
Terms.Tech serves the European medical device BNPL market with EEA-wide coverage and deep understanding of EU Medical Device Regulation (MDR) compliance requirements.
Backed by Credendo with over 100 years of credit insurance experience, Terms.Tech provides rigorous risk assessment specifically calibrated for European medical device markets. The platform supports payment terms of 30, 60, 90, or 120 days throughout the EEA plus Switzerland.
The European medical device market is estimated at over $140 billion and experiencing steady growth, making Terms.Tech a valuable solution for manufacturers with European operations. The platform's understanding of cross-border payment complexities and local regulatory requirements streamlines international medical device sales.
Splitit leverages buyers' existing business credit card limits to enable instant purchasing decisions during critical equipment demonstrations and sales conversations.
Splitit uses buyers' existing credit card relationships to split payments into manageable installments over time, eliminating the need for credit applications and underwriting. Medical equipment vendors report higher close rates, increased average deal sizes, and shortened sales cycles when using Splitit.
Splitit handles transactions of any size, limited only by the buyer's existing credit card limit. This makes it suitable for medical devices ranging from smaller diagnostic equipment to high-value surgical systems.
Billtrust specializes in the unique complexities of medical device order-to-cash and payment operations, including AP provider portal challenges, merger-driven billing complications, and high-value transaction fee optimization.
Billtrust's platform addresses the reality that medical device payments are 100 times more complex than other B2B verticals. The platform achieves an 86.3% cash application match rate for complex medical payments, delivering 50-80% productivity increases for operations teams.
On typical high-value medical device transactions, Billtrust's Level 2/3 data processing can reduce interchange fees by up to 30%, providing significant savings compared to standard processing. This fee reduction directly impacts manufacturer profitability on large equipment sales.
Sunbit has emerged as a prominent BNPL provider for healthcare services, with extensive healthcare provider partnerships and high approval rates for applicants.
Sunbit's healthcare specialization and rapid growth make it increasingly relevant for medical device manufacturers, particularly for mid-range equipment. The platform's high approval rate ensures maximum buyer accessibility across diverse customer segments.
Sunbit demonstrates strong growth in the BNPL space with 675% search growth over 5 years and significant funding rounds supporting rapid expansion. Healthcare represents the fastest-growing BNPL vertical at 20.4% CAGR through 2030, according to industry analysis.
eCapital brings extensive financing experience to medical device manufacturers, with substantial facility capacity and a long-term partnership approach.
With thousands of clients financed over nearly two decades, eCapital offers the stability and scale required by larger medical device manufacturers. The platform provides 30, 60, or 90-day payment terms to buyers while ensuring sellers receive full upfront payment.
eCapital maintains a dedicated healthcare financing division with deep understanding of medical device industry requirements, regulatory considerations, and payment cycle complexities.
Affirm brings consumer-grade user experience and substantial scale to healthcare financing, with strong year-over-year revenue growth and active expansion into medical procedures and devices.
As a leading consumer BNPL provider, Affirm is strategically expanding into healthcare with growing medical merchant adoption. The platform's consumer familiarity and brand recognition accelerate buyer adoption in medical device sales.
Affirm specializes in higher-value transactions suitable for medical devices, offering flexible payment terms. The platform's partnership with healthcare CRM providers facilitates direct access to medical practices and equipment buyers.
Paystand positions a subscription-based model that can reduce or eliminate per-transaction fees on certain payment rails, using its network and automation infrastructure, addressing the critical pain point of percentage-based fees on high-value transactions.
On high-value medical device transactions, traditional payment processors charge substantial percentage-based fees. Paystand's model eliminates these costs through subscription-based pricing and blockchain technology.
Healthcare organizations implementing Paystand have seen their DSO metrics improve significantly, demonstrating the platform's effectiveness in healthcare settings.
Hokodo provides comprehensive European B2B BNPL solutions with end-to-end order-to-cash coverage and fast credit decisions.
As a European B2B BNPL provider, Hokodo offers medical device manufacturers a reliable European payment solution with local compliance understanding and regional market expertise.
Hokodo's end-to-end platform covers the entire order-to-cash cycle, ensuring consistent buyer experience and streamlined operations for manufacturers across European markets.
TreviPay specializes in large-scale B2B implementations with global cross-border capabilities and white-labeled customer experiences for enterprise medical device manufacturers.
TreviPay's platform is designed for enterprise-level medical device manufacturers with complex international operations, offering custom payment terms and white-labeled experiences that maintain manufacturer brand identity throughout the payment process.
The platform scales payment models globally with enterprise-grade onboarding processes, making it suitable for multinational medical device companies with diverse market requirements.
Industry Specialization Matters: Medical device transactions average $230,000—significantly higher than other B2B verticals. Platforms like Resolve that are purpose-built for medical devices understand the unique requirements around healthcare compliance, high-value transactions, and complex sales cycles.
Risk Management Approach: Non-recourse financing eliminates manufacturer liability for buyer defaults, while recourse models transfer risk back to the seller. For medical device manufacturers dealing with high-value transactions, non-recourse protection provides critical financial security.
Integration Requirements: Seamless integration with existing ERP and accounting systems prevents operational disruption. Resolve's comprehensive integrations with QuickBooks, NetSuite, Sage, and major e-commerce platforms ensure smooth implementation without manual data entry.
Geographic Coverage: European manufacturers need platforms with EU MDR compliance understanding, while US-focused companies benefit from healthcare-specific infrastructure tailored to domestic regulatory requirements.
Fee Structure Impact: On high-value transactions, percentage-based fees can be substantial. Platforms that eliminate or significantly reduce transaction costs provide meaningful cost advantages that directly impact profitability.
When evaluating B2B BNPL platforms for medical device manufacturing, Resolve delivers the most comprehensive, purpose-built solution for the industry's unique challenges. The platform's combination of non-recourse financing, AI-powered credit decisions, and healthcare compliance expertise addresses the core pain points that medical device manufacturers face when offering competitive payment terms.
Resolve's 24-hour payment advancement transforms cash flow management from a constraint into a competitive advantage. Manufacturers can confidently offer Net 60-90 terms knowing they'll receive up to 90% of invoice value within 24 hours, enabling them to invest in inventory, R&D, and growth initiatives without waiting months for customer payments. This cash flow certainty becomes especially valuable for manufacturers managing complex production cycles and high-value component procurement.
The platform's non-recourse model provides unmatched protection for high-value medical device transactions. Unlike recourse financing where manufacturers remain liable for buyer defaults, Resolve's non-recourse cash advances mean what you receive is always yours to keep. This risk transfer becomes critically important when individual transactions average $230,000—a single default could significantly impact financial performance without non-recourse protection.
Resolve's AI-powered credit assessment delivers the speed and accuracy essential for modern medical device sales. The platform evaluates thousands of buyer data points to generate instant credit decisions, enabling frictionless purchasing experiences that help close deals during critical sales conversations. Manufacturers can offer terms confidently knowing Resolve's proprietary models—built by experts from Amazon, PayPal, and Fortune 500 companies—provide deeper credit insights than traditional bureaus.
For medical device manufacturers ready to transform payment terms from a competitive liability into a sales growth engine, Resolve provides the specialized platform, healthcare expertise, and proven results that drive measurable business outcomes. Visit resolvepay.com to explore how Resolve can enhance your competitive position while protecting cash flow and eliminating credit risk.
Medical device manufacturers benefit uniquely from B2B BNPL because their transactions average $230,000—far larger than many B2B industries—creating major cash-flow strain when offering Net 60–90. Medical buyers also face long procurement and budget cycles, increasing the need for extended terms. BNPL platforms like Resolve pay manufacturers immediately while giving qualified buyers flexible terms, closing the cash gap that limits growth. Research from McKinsey links stronger customer experience to higher revenue.
Resolve’s AI models analyze thousands of buyer data points to deliver dynamic credit decisions within 24 hours, balancing speed with accuracy at scale. With experts formerly from Amazon, PayPal, and Fortune 500 firms, the platform can provide deeper insights than traditional bureaus alone. For medical device buyers, this means fast approvals with minimal friction—no paperwork and no waiting—so purchasing momentum isn’t lost during demos or sales conversations. Resolve performs comprehensive credit checks discreetly, typically requiring only basic company information, enabling a smoother checkout experience.
Yes. Resolve provides comprehensive integrations with major ERP, accounting, and commerce platforms including QuickBooks, NetSuite, Sage Intacct, Oracle, Shopify, BigCommerce, Magento, and WooCommerce. It fits into your existing B2B ecommerce and finance stack through plug-ins, flexible APIs, and automated syncing. Resolve can sync customer and transaction data to reduce manual entry, streamline reconciliation, and support clean financial reporting. This integration approach helps manufacturers add flexible payment terms without disrupting established workflows or creating extra operational overhead.
Resolve manages credit approval, underwriting, and collections end-to-end so medical device manufacturers can offer terms without tying up internal resources. The platform uses AI agents to automate payment reminders and reduce friction, and it can provide manual collections support when needed. For high-value device orders, Resolve’s non-recourse structure means manufacturers can receive up to 100% of invoice value upfront, removing exposure to late payments or default risk. Resolve handles follow-ups and collections activity, letting your team stay focused on selling and customer relationships.
Resolve positions its cash advances as truly non-recourse for manufacturers: all cash advances are non-recourse, meaning funds received are yours to keep regardless of buyer payment behavior. Resolve conducts credit assessment and decisions and assumes the majority of late-payment and default risk. This matters especially for medical device manufacturers with large invoice sizes, where bad-debt exposure can be painful. By removing payment friction while keeping cash flow predictable, manufacturers can offer competitive terms that support loyalty and growth—an outcome aligned with Accenture research on experience-driven loyalty.
This post is to be used for informational purposes only and does not constitute formal legal, business, or tax advice. Each person should consult his or her own attorney, business advisor, or tax advisor with respect to matters referenced in this post. Resolve assumes no liability for actions taken in reliance upon the information contained herein.